- Home
- CTLP vs LAB Comparison
CTLP vs LAB Comparison
Compare CTLP & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTLP
- LAB
- Stock Information
- Founded
- CTLP 1992
- LAB 1999
- Country
- CTLP United States
- LAB United States
- Employees
- CTLP N/A
- LAB N/A
- Industry
- CTLP EDP Services
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- CTLP Technology
- LAB Industrials
- Exchange
- CTLP Nasdaq
- LAB Nasdaq
- Market Cap
- CTLP 670.7M
- LAB 642.1M
- IPO Year
- CTLP N/A
- LAB 2011
- Fundamental
- Price
- CTLP $8.72
- LAB $1.58
- Analyst Decision
- CTLP Strong Buy
- LAB Strong Buy
- Analyst Count
- CTLP 4
- LAB 2
- Target Price
- CTLP $11.50
- LAB $2.88
- AVG Volume (30 Days)
- CTLP 416.0K
- LAB 2.5M
- Earning Date
- CTLP 11-07-2024
- LAB 10-30-2024
- Dividend Yield
- CTLP N/A
- LAB N/A
- EPS Growth
- CTLP 15.90
- LAB N/A
- EPS
- CTLP 0.17
- LAB N/A
- Revenue
- CTLP $276,749,000.00
- LAB $155,902,000.00
- Revenue This Year
- CTLP $18.92
- LAB $62.60
- Revenue Next Year
- CTLP $14.85
- LAB $9.91
- P/E Ratio
- CTLP $51.28
- LAB N/A
- Revenue Growth
- CTLP 11.35
- LAB 48.23
- 52 Week Low
- CTLP $5.75
- LAB $1.21
- 52 Week High
- CTLP $9.67
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- CTLP 47.06
- LAB 34.81
- Support Level
- CTLP $8.53
- LAB $2.12
- Resistance Level
- CTLP $9.67
- LAB $2.26
- Average True Range (ATR)
- CTLP 0.28
- LAB 0.17
- MACD
- CTLP -0.10
- LAB -0.04
- Stochastic Oscillator
- CTLP 16.67
- LAB 1.33
About CTLP Cantaloupe Inc.
Cantaloupe Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Cashless devices, eSuds, EnergyMisers, and Value-added services which include Loyalty and Prepaid, Intelligent Vending, and others. The company offers services to different industries covering car wash, taxi and transportation, laundry, vending, kiosk, amusement, and arcade. The company derives revenue from the sale or lease of equipment and services to the small ticket, unattended POS market, and the majority of its revenue is derived from subscription and transaction fees.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.